SMTL ID : 4frs.2 (1 other biounit)

Structure of BACE in complex with (S)-4-(3-chloro-5-(5-(prop-1-yn-1-yl)pyridin-3-yl)thiophen-2-yl)-1,4-dimethyl-6-oxotetrahydropyrimidin-2(1H)-iminium

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.70 Å

Oligo State

monomer

Ligands

1 x 0V6: (2Z,6S)-6-{3-CHLORO-5-[5-(PROP-1-YN-1-YL)PYRIDIN-3-YL]THIOPHEN-2-YL}-2-IMINO-3,6-DIMETHYLTETRAHYDROPYRIMIDIN-4(1H)-ONE(Non-covalent)

0V6.1: 19 residues within 4Å: Chain A: S.19, Q.21, G.22, L.39, D.41, G.43, S.44, Y.80, Q.82, G.83, F.117, I.119, W.124, D.237, S.238, G.239, T.240, T.241, A.344 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:L.39, A:Y.80, A:Y.80, A:Q.82, A:A.344 Water bridges: A:G.43, A:Q.82 Salt bridges: A:D.41, A:D.237 Halogen bonds: A:G.83

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Stamford, A.W. et al., Discovery of an Orally Available, Brain Penetrant BACE1 Inhibitor That Affords Robust CNS A(beta) Reduction. ACS Med Chem Lett (2012)

Release Date

2012-08-08

Peptides

Beta-secretase 1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

Beta-secretase 1

Related Entries With Identical Sequence